Abstract
Purpose of Review
This article seeks to summarize the history of patient-based monitoring systems for age-related macular degeneration, as well as recent new and emerging technologies in the field of home surveillance.
Recent Findings
New commercially available products, such as ForeseeHome and Paxos, offer improved modalities for home monitoring of macular degeneration, and home optical coherence tomography provides the potential for further improvement in the future.
Summary
While traditional Amsler grid monitoring has provided a useful test for patients to monitor their vision, it has found to have limited specificity and sensitivity as a screening tool for neovascular macular degeneration. Technologies such as ForeseeHome offer a new standard of care with improved accuracy in detection neovascularization early in its disease course, allowing for early intervention to improve patient outcomes.
Similar content being viewed by others
References
Marmor MF. A brief history of macular grids: from Thomas Reid to Edvard Munch and Marc Amsler. Surv Ophthalmol. 2000;44(4):343–53. https://doi.org/10.1016/S0039-6257(99)00113-7.
Augustin AJ, Offermann I, Lutz J, Schmidt-Erfurth U, Tornambe P. Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration. Retina. 2005;25(4):443–5. https://doi.org/10.1097/00006982-200506000-00008.
Schlaegel TF Jr, Cofield DD, Clark G, et al. Photocoagulation and other therapy for histoplasmic choroiditis. Trans Am Acad Ophthalmol Otolaryngol. 1968;72(3):355–63.
The Macular Photocoagulation Study Group. Early detection of extrafoveal neovascular membranes by daily central field evaluation. Ophthalmology. 1985;92:603–9.
Schuchard RA. Validity and interpretation of Amsler grid reports. Arch Ophthalmol. 1993;111(6):776–80. https://doi.org/10.1001/archopht.1993.01090060064024.
Zaidi FH, Cheong-Leen R, Gair EJ, Weir R, Sharkawi E, Lee N, et al. The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey Eye. 2004;18(5):503–8. https://doi.org/10.1038/sj.eye.6700708.
Trevino R. Recent progress in macular function self-assessment. Ophthalmic Physiol Opt. 2008;28(3):183–92. https://doi.org/10.1111/j.1475-1313.2008.00561.x.
Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E, et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology. 2003;110(5):966–70. https://doi.org/10.1016/S0161-6420(03)00074-5.
Elman MJ. Home monitoring of dry AMD patients. Retina Today. 2016;11:76–8.
Trevino R, Kynn MG. Macular function surveillance revisited. Optometry. 2008;79(7):397–403. https://doi.org/10.1016/j.optm.2007.09.017.
The Preferential Hyperacuity Perimeter Research Group. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina. 2005;25(3):296–303. https://doi.org/10.1097/00006982-200504000-00008.
The Preferential Hyperacuity Perimetry Research Group. Preferential hyperacuity perimeter for detecting choroidal neovascularization study. Ophthalmology. 2005a;112:1758–65.
Kampmeier J, Zorn MM, Lang GK, Botros YT, Lang GE. Vergleich des Preferential-Hyperacuity-Perimeter (PHP)-tests mit dem Amsler-netz-test bei der diagnose verschiedener stadien der altersbezogenen makuladegeneration. Klin Monatsbl Augenheilkd. 2006;223(9):752–6. https://doi.org/10.1055/s-2006-926880.
Loewenstein A, Ferencz JR, Lang Y, Yeshurun I, Pollack A, Siegal R, et al. Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration: multicenter evaluation of a preferential hyperacuity perimeter designed as a home device. Retina. 2010;30(7):1058–64. https://doi.org/10.1097/IAE.0b013e3181d1a75e.
Chew EY, Clemons TE, Bressler SB, AREDS2-Home Study Research Group, et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the eye (HOME) study. Ophthalmology. 2014;121(2):535–44. https://doi.org/10.1016/j.ophtha.2013.10.027.
Kirkner RM. An app to monitor patients at home. Retina Specialist. 2016;5:44.
Yu SY, Yang JH, Kim Y, et al. Reliability of smartphone-based electronic visual acuity testing: (applications in remote monitoring and clinical research of macular pathology). Invest Ophthalmol Vis Sci. 2014;55(13):5598.
Blumenkranz MS. The power of more data in managing AMD. Retin Physician. 2016;13:58–70.
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - . Identifier NCT02871817, A comparison of the Paxos Mobile App to Standard Vision Assessment Tools (CLEAR); 2017 [cited 2017 Sept 30]; Available from: https://clinicaltrials.gov/ct2/show/NCT02871817
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - . Identifier NCT01863199, Impact of home monitoring to decrease the treatment burden for neovascular age-related macular degeneration (AMD) (Liberty); 2015 [cited 2017 Sept 30]; Available from: https://clinicaltrials.gov/ct2/show/NCT01863199
Harrison L. Smartphones hold implications for retinal screening, beyond. Modern Retina [Internet]. 2016 Feb [cited 2017 Sept 30]; Available from: http://modernretina.modernmedicine.com/modern-retina/news/smartphones-hold-implications-retinal-screening-beyond
Toy BC, Myung DJ, He L, Pan CK, Chang RT, Polkinhorne A, et al. Smartphone-based dilated fundus photography and near visual acuity testing as inexpensive screening tools to detect referral warranted diabetic eye disease. Retina. 2016;36(5):1000–8. https://doi.org/10.1097/IAE.0000000000000955.
Mallipatna A, Vinekar A, Jayadev C, Dabir S, Sivakumar M, Krishnan N, et al. The use of handheld spectral domain optical coherence tomography in pediatric ophthalmology practice: our experience of 975 infants and children. Indian J Ophthalmol. 2015;63(7):586–93. https://doi.org/10.4103/0301-4738.167108.
Maldonado RS, Izatt JA, Sarin N, Wallace DK, Freedman S, Cotten CM, et al. Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. Invest Ophthalmol Vis Sci. 2010;51(5):2678–85. https://doi.org/10.1167/iovs.09-4403.
Subhash HM, Hogan JN, Leahy MJ. Multiple-reference optical coherence tomography for smartphone applications. SPIE. 2015; https://doi.org/10.1117/2.1201503.005807.
Notal Vision welcomes Roni Amiel as Chief Information Officer [Internet]. 2017 [cited 2017 Sept 30]; Available from: http://www.prnewswire.com/news-releases/notal-vision-welcomes-roni-amiel-as-chief-information-officer-300497437.html
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Kevin Miller and Jorge Fortun declare no conflict of interest.
Jorge Fortun is a consultant for Notal Vision
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Retina
Rights and permissions
About this article
Cite this article
Miller, K.P., Fortun, J.A. Home Monitoring for Age-related Macular Degeneration. Curr Ophthalmol Rep 6, 53–57 (2018). https://doi.org/10.1007/s40135-018-0163-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40135-018-0163-6